Opportunity sizing of oral oncology medication waste at a health system specialty pharmacy
NCODA Oncology and Hematology Meeting Abstracts · 15.06.2026
DOI: 10.67209/boct9617 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 15.06.2026. Verfasst von Kleona Kolludra und 5 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Cancer is among the leading causes of death in the United States of America (USA), and the rising costs of treatment play a significant role on the economic burden of the healthcare system. While oral oncology medications provide many advantages (e.g., convenience of home administration, non-invasive treatment, etc.), several factors can result in medication waste, including therapy holds, dose modifications, treatment discontinuation due to therapy intolerance, transitions of care, or disease progression. These recurrent changes in oral oncology medications may consequently result in waste and superfluous cost to the payer and/or patient.
Zitieren
APA
Kolludra, K., Patel, Z., Lindner, C., Wang, T., Stutsky, M., & Chun, C. (2026). Opportunity sizing of oral oncology medication waste at a health system specialty pharmacy. NCODA Oncology and Hematology Meeting Abstracts. https://doi.org/10.67209/boct9617
Vancouver
Kolludra K, Patel Z, Lindner C, Wang T, Stutsky M, Chun C. Opportunity sizing of oral oncology medication waste at a health system specialty pharmacy. NCODA Oncology and Hematology Meeting Abstracts. 2026. doi:10.67209/boct9617
BibTeX
@article{Kolludra2026,
author = {Kolludra, Kleona and Patel, Zarna and Lindner, Chelsey and Wang, Tincey and Stutsky, Martha and Chun, Caleb},
title = {Opportunity sizing of oral oncology medication waste at a health system specialty pharmacy},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
doi = {10.67209/boct9617}
}
EUVIMED